(Updated - October 29, 2021 5:42 AM EDT)

Cowen analyst Joshua Jennings initiates coverage on Humacyte (NASDAQ: HUMA) with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE